Put Options

9 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$69.02 - $93.84 $5.31 Million - $7.22 Million
76,900 Added 38.74%
275,400 $19.4 Million
Q2 2024

Aug 15, 2024

SELL
$74.43 - $92.22 $1.06 Million - $1.32 Million
-14,300 Reduced 6.72%
198,500 $16.3 Million
Q1 2024

May 07, 2024

BUY
$83.81 - $99.0 $4.07 Million - $4.81 Million
48,600 Added 29.6%
212,800 $18.6 Million
Q4 2023

Feb 14, 2024

BUY
$76.22 - $98.51 $3.94 Million - $5.09 Million
51,700 Added 45.96%
164,200 $15.8 Million
Q3 2023

Nov 14, 2023

SELL
$85.07 - $94.48 $9.26 Million - $10.3 Million
-108,800 Reduced 49.16%
112,500 $9.95 Million
Q2 2023

Aug 11, 2023

SELL
$86.68 - $100.3 $2.22 Million - $2.57 Million
-25,600 Reduced 10.37%
221,300 $19.2 Million
Q1 2023

May 16, 2023

BUY
$87.74 - $117.27 $2.13 Million - $2.85 Million
24,300 Added 10.92%
246,900 $24 Million
Q4 2022

Feb 14, 2023

BUY
$80.93 - $108.63 $11.6 Million - $15.6 Million
143,300 Added 180.71%
222,600 $23 Million
Q3 2022

Nov 14, 2022

BUY
$82.16 - $96.94 $1.17 Million - $1.39 Million
14,300 Added 22.0%
79,300 $6.72 Million

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.3B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.